NDC 76381-316-52 - ISOVUE 200
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76381-316
- Requested NDC
- 76381-316-52
- Package NDCs from labels
- 76381-316-01, 76381-316-52, 76381-316-35, 76381-316-04, 76381-316-37, 76381-316-30
- Manufacturer
- BIPSO GmbH | Takeda GmbH | BRACCO IMAGING SPA
- Effective date
- 2018-12-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ISOVUE 200 - BIPSO GmbH | Takeda GmbH | BRACCO IMAGING SPA | BIPSO GmbH | Takeda GmbH | BRACCO IMAGING SPA | 2018-12-17 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| iopamidol | IOPAMIDOL | Slate Run Pharmaceuticals, LLC | 0b9e0d24-c6ca-4e22-9422-936e9d475eaa | 2026-07-23 | Warnings, Adverse reactions | JR13W81H44 |
| THAM | TROMETHAMINE | Hospira, Inc. | 4af52118-c12b-4ad5-30bb-959848357e8a | 2026-05-27 | Warnings, Adverse reactions | 023C2WHX2V |
| ISOVUE 200 | IOPAMIDOL | BRACCO DIAGNOSTICS INC | ae8c18c9-3e7d-4515-b980-120025a88fc1 | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | NDA018735 JR13W81H44 |
| ISOVUE 300 | IOPAMIDOL | Bracco Diagnostics Inc | 797a11d7-dcd4-43ff-311b-3b48a10da2f2 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | NDA020327 JR13W81H44 |
| ISOVUE-M | IOPAMIDOL | Bracco Diagnostics Inc | 11e893d2-0183-4581-b908-c8b7302c7edb | 2026-02-10 | Warnings, Adverse reactions | NDA018735 JR13W81H44 |
| Tromethamine | TROMETHAMINE | MILLA PHARMACEUTICALS INC. | 082b1104-502b-47af-95bf-0dbf2422990e | 2026-01-07 | Warnings, Adverse reactions | 023C2WHX2V |
| iopamidol | IOPAMIDOL | Slate Run Pharmaceuticals, LLC | 69e9ab05-88f8-45f9-8bc1-ed33ab1385f0 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | JR13W81H44 |
| Edetate Calcium Disodium | EDETATE CALCIUM DISODIUM | Rising Pharma Holdings, Inc. | 710a2c8c-3620-4f6f-b8fc-fb19ab9e9f22 | 2025-02-13 | Boxed warning, Warnings, Adverse reactions | 25IH6R4SGF |
| TROMETHAMINE | TROMETHAMINE | B. Braun Medical Inc. | 57db5686-7f7f-4999-87e3-e1cbbda4a98d | 2024-12-23 | Warnings, Adverse reactions | 023C2WHX2V |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 023C2WHX2V |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 023C2WHX2V |
| 5c4ac062-d59d-f667-f218-1572e3d8cde8 | 764f5085-7ee8-fdba-2c5b-ae6721014a94 | 2018-12-17 | Boxed warning, Warnings, Adverse reactions | 5c4ac062-d59d-f667-f218-1572e3d8cde8 764f5085-7ee8-fdba-2c5b-ae6721014a94 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.